Therapeutic Effects of Growth Factor Cocktail Including Fibroblast Growth Factor 9 in Patients with Androgenetic Alopecia: A Split Study

In a study conducted 7 years ago on 18 patients with androgenetic alopecia, a treatment involving a growth factor cocktail (GFC) called Cellcurin, which includes fibroblast growth factor 9, was applied in combination with microneedling for three months. The results showed a significant increase in hair density and diameter on the side of the scalp treated with Cellcurin compared to the side treated with normal saline. Specifically, the Cellcurin-treated side showed a 27.1/cm2 increase in hair density and a 2.7µm change in hair diameter. The study concluded that Cellcurin treatment was effective and safe, and seemed to be more effective than SGF57, a GFC without FGF9. However, the study had limitations such as a relatively small number of patients and a short study period.